Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

Coagulation

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

Disorders of Hemostasis

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Molecular mechanisms of naturally encoded signaling bias at the complement anaphylatoxin receptors.

Molecular cell·2026

Same author

Asking AI About Your Car: AI-Augmented Vehicle Owner's Manuals Support Integrated System Understanding Beyond Traditional Documentation.

Human factors·2026

Same author

Complement dysregulation in multiple sclerosis: emerging mechanisms and translational therapeutic opportunities.

Trends in pharmacological sciences·2026

Same author

With a Little Help From My Car: Sharing Automated Vehicle's Situation Awareness Reduces Driver-Initiated Automation Disengagement Without Delaying Takeover Response Time.

Human factors·2026

Same author

Complement-mediated and direct activation of human neutrophils induced by <i>Premolis semirufa</i> caterpillar toxins.

Frontiers in immunology·2026

Same author

Consumption of processed foods impairs memory function through dietary advanced glycation end-products.

bioRxiv : the preprint server for biology·2026

Same journal

IL-33 scripts cancer immunity.

Trends in immunology·2026

Same journal

Mitochondrial Ca<sup>2+</sup> signaling: A metabolic rheostat defining tumor and immune cell fate.

Trends in immunology·2026

Same journal

Cross-priming underlies the efficacy of antibody-drug conjugates and immunotherapy combinations.

Trends in immunology·2026

Same journal

Gut microbiome metabolites meet immunometabolism in inflammatory bowel disease.

Trends in immunology·2026

Same journal

Metabolic regulatory nodes of the inflammasome and inflammatory cell death.

Trends in immunology·2026

Same journal

Parental leave in immunology - 6.

Trends in immunology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 28, 2025

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Complement(ing) long-COVID thromboinflammation and pathogenesis.

John D Lee¹, Trent M Woodruff²

¹School of Biomedical Sciences, University of Queensland, St Lucia, Brisbane, QLD, 4072, Australia.

Trends in Immunology

|April 18, 2024

Summary

This summary is machine-generated.

Long COVID, a persistent condition after SARS-CoV-2 infection, involves complex immune responses. Research reveals a link between complement and coagulation systems, influenced by antiviral antibodies and tissue damage, offering insights into this challenging health issue.

Keywords:

SARS-CoV-2 coagulation complement inflammation long COVID

More Related Videos

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

Related Experiment Videos

Last Updated: Jun 28, 2025

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

Area of Science:

Immunology
Infectious Diseases
Pathophysiology

Background:

Long COVID, characterized by persistent symptoms post-SARS-CoV-2 infection, poses a significant global health challenge.
Understanding the underlying immunological mechanisms of long COVID is crucial for developing effective treatments.

Purpose of the Study:

To investigate the immunological landscape in patients experiencing long COVID.
To explore the interplay between the complement and coagulation systems in the context of long COVID.

Main Methods:

The study analyzed immunological markers in patients with long COVID.
Investigated the roles of antiviral antibodies and tissue damage in disease pathogenesis.

Main Results:

Demonstrated a significant interplay between the complement and coagulation pathways in long COVID patients.
Identified antiviral antibodies and tissue damage as key drivers of this immune dysregulation.

Conclusions:

The findings highlight a complex immunological interplay contributing to long COVID.
Suggests that targeting complement and coagulation pathways may offer therapeutic strategies for long COVID management.